HSK-39775

N/A

Report date: 2024/11/27 16:46:42
NME

Base Information

Drug NameHSK-39775
Drug Alias NameHSK39775HSK-39775
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUbiquitin carboxyl-terminal hydrolase 1 inhibitors
TargetsUbiquitin carboxyl-terminal hydrolase 1
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesTibet Haisco Pharmaceutical Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesTibet Haisco Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A